VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Coherus Oncology, Inc. (CHRS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biological Products, (No Diagnostic Substances) · market value about $128M · revenue $50.9M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows